Cavos Bio
Cavos Bio is a biotech company in Jerusalem, Israel, founded in 2021. It has raised $3.4M across 1 round, most recently a $3.4M Seed in November 2024.
Validated by nature
- Headquarters
- Jerusalem
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Total Funding
- $3.4M
- Last Round
- $3.4M SeedNov 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
caVos Biotherapeutics is a preclinical biotech startup founded out of The Hebrew University of Jerusalem. The company uses a multi-level genomic algorithm and comparative genomics to identify the genetic basis of extraordinary cancer resistance observed across various animal species, with the goal of uncovering novel anti-cancer drug targets and mRNA therapeutics. caVos leverages advanced data science and AI to translate nature's own cancer-resistance mechanisms into precision medicine drug candidates, targeting both oncology and longevity-related indications such as fibrosis. The company was recognized as one of the Most Innovative Life Science Startups at Biomed Israel 2026.
Summary
It lists 1–10 employees. It has raised $3.4M in total across 1 round, most recently a $3.4M Seed round in Nov 2024. Investors include Alumni Ventures.
Funding History
Nov 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cavos-bio"><img src="https://indexed.vc/api/badge/company/cavos-bio" alt="Cavos Bio on Indexed.vc" width="260" height="76" /></a>